Your browser doesn't support javascript.
loading
Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart Disease.
Elias, Pierre; Poterucha, Timothy J; Rajaram, Vijay; Moller, Luca Matos; Rodriguez, Victor; Bhave, Shreyas; Hahn, Rebecca T; Tison, Geoffrey; Abreau, Sean A; Barrios, Joshua; Torres, Jessica Nicole; Hughes, J Weston; Perez, Marco V; Finer, Joshua; Kodali, Susheel; Khalique, Omar; Hamid, Nadira; Schwartz, Allan; Homma, Shunichi; Kumaraiah, Deepa; Cohen, David J; Maurer, Mathew S; Einstein, Andrew J; Nazif, Tamim; Leon, Martin B; Perotte, Adler J.
Afiliação
  • Elias P; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.
  • Poterucha TJ; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.
  • Rajaram V; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.
  • Moller LM; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.
  • Rodriguez V; Department of Biomedical Informatics, Columbia University, New York, New York, USA.
  • Bhave S; Department of Biomedical Informatics, Columbia University, New York, New York, USA.
  • Hahn RT; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.
  • Tison G; Division of Cardiology, University of California-San Francisco, San Francisco, California, USA.
  • Abreau SA; Division of Cardiology, University of California-San Francisco, San Francisco, California, USA.
  • Barrios J; Division of Cardiology, University of California-San Francisco, San Francisco, California, USA.
  • Torres JN; Division of Cardiology, Stanford University, Palo Alto, California, USA.
  • Hughes JW; Division of Cardiology, Stanford University, Palo Alto, California, USA.
  • Perez MV; Division of Cardiology, Stanford University, Palo Alto, California, USA.
  • Finer J; NewYork-Presbyterian Hospital, New York, New York, USA.
  • Kodali S; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.
  • Khalique O; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.
  • Hamid N; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.
  • Schwartz A; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.
  • Homma S; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.
  • Kumaraiah D; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.
  • Cohen DJ; Cardiovascular Research Foundation, New York, New York, USA; Department of Cardiology, St. Francis Hospital, Roslyn, New York, USA.
  • Maurer MS; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.
  • Einstein AJ; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.
  • Nazif T; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA.
  • Leon MB; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, New York, USA; Cardiovascular Research Foundation, New York, New York, USA.
  • Perotte AJ; Department of Biomedical Informatics, Columbia University, New York, New York, USA. Electronic address: adler.perotte@columbia.edu.
J Am Coll Cardiol ; 80(6): 613-626, 2022 08 09.
Article em En | MEDLINE | ID: mdl-35926935
ABSTRACT

BACKGROUND:

Valvular heart disease is an important contributor to cardiovascular morbidity and mortality and remains underdiagnosed. Deep learning analysis of electrocardiography (ECG) may be useful in detecting aortic stenosis (AS), aortic regurgitation (AR), and mitral regurgitation (MR).

OBJECTIVES:

This study aimed to develop ECG deep learning algorithms to identify moderate or severe AS, AR, and MR alone and in combination.

METHODS:

A total of 77,163 patients undergoing ECG within 1 year before echocardiography from 2005-2021 were identified and split into train (n = 43,165), validation (n = 12,950), and test sets (n = 21,048; 7.8% with any of AS, AR, or MR). Model performance was assessed using area under the receiver-operating characteristic (AU-ROC) and precision-recall curves. Outside validation was conducted on an independent data set. Test accuracy was modeled using different disease prevalence levels to simulate screening efficacy using the deep learning model.

RESULTS:

The deep learning algorithm model accuracy was as follows AS (AU-ROC 0.88), AR (AU-ROC 0.77), MR (AU-ROC 0.83), and any of AS, AR, or MR (AU-ROC 0.84; sensitivity 78%, specificity 73%) with similar accuracy in external validation. In screening program modeling, test characteristics were dependent on underlying prevalence and selected sensitivity levels. At a prevalence of 7.8%, the positive and negative predictive values were 20% and 97.6%, respectively.

CONCLUSIONS:

Deep learning analysis of the ECG can accurately detect AS, AR, and MR in this multicenter cohort and may serve as the basis for the development of a valvular heart disease screening program.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência da Valva Aórtica / Estenose da Valva Aórtica / Aprendizado Profundo / Doenças das Valvas Cardíacas / Insuficiência da Valva Mitral Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência da Valva Aórtica / Estenose da Valva Aórtica / Aprendizado Profundo / Doenças das Valvas Cardíacas / Insuficiência da Valva Mitral Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2022 Tipo de documento: Article